Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research explores respiratory health of Boston terriers
Researchers say prioritising respiratory function is vital for the welfare of the breed.
The BOAS Research Group investigated how brachycephaly affects the breed.

New research into the breathing function of Boston terriers has revealed the impact that brachycephaly has on their health.

The brachycephalic obstructive airway syndrome (BOAS) Research Group, based at the University of Cambridge, examined how the risk factors relating to brachycephalic (flat-faced) breeds could lead to the development of respiratory disease.

The study revealed that, while the breed is affected by BOAS, Boston terriers were less severely affected than other popular brachycephalic breeds. Research into the breed revealed that 62.5 per cent of Boston terriers were unaffected by BOAS.

The key risk factors for BOAS which were identified in Boston terriers included stenotic nostrils, facial foreshortening, abnormal scleral show and a higher neck-to-girth ratio.

Despite finding that Boston terriers were less severely affected by BOAS, researchers say their findings highlight the importance of responsible breeding of dogs. They state that prioritising better respiratory function and avoiding extreme conformational traits is vital for protecting the welfare of the breed.

Similarly, the action group is asking that prospective pet owners consider the animal’s health over its appearance.

The project was funded by The Kennel Club Charitable Trust, as the Kennel Club seeks to develop its resources. This includes Breed Watch, a Respiratory Function Grading Scheme, and Breed Health and Conservation Plans.

The Kennel Club says that its Breed Health and Conservation Plans, developed from over 4,000 research papers, makes the project the most comprehensive review of pedigree health data anywhere in the world.

Charlotte McNamara, head of health at The Kennel Club, said: “While breeders now have more information to make healthier breeding decisions, we also urge prospective owners to prioritise health over appearance when choosing a dog.

“Decisions should not be driven by celebrity trends or social media influence but by finding breeders who use the health tools available and prioritise non-exaggerated features, ensuring that health comes first, as described in the breed standard.”

The full study can be found in the journal Plos One.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.